Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib Adjuvant Therapy in Stomach Cancer
NCT00164892Phase 3Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rofecoxib in gastric cancer (GC), sponsored by The Chinese University of Hong Kong. Status: unknown.
02
Drugs
rofecoxib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00164892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164892.